MiNK Therapeutics INKT
NASDAQ INKT
$12.20 +0.58 (+4.99%)
At close: Aug 21, 2026 · 4:00 PM EDT

MiNK Therapeutics (INKT) Property, Plant & Equipment (Net) (2020 - 2026)

MiNK Therapeutics (INKT) Property, Plant & Equipment (Net) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 2.06 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 1.64 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 554.14 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 6.80 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 107.22 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 MiNK Therapeutics 60.53 Mn 60.53 Mn - 318,474.00

Historic Data

Download Data
DateValue
Jun 30, 2026 318,474.00
Jun 30, 2026 318,474.00
Mar 31, 2026 354,518.00
Mar 31, 2026 354,518.00
Dec 31, 2025 390,869.00
Dec 31, 2025 390,869.00
Sep 30, 2025 429,344.00
Sep 30, 2025 429,344.00
Jun 30, 2025 473,215.00
Jun 30, 2025 473,215.00
Mar 31, 2025 687,500.00
Mar 31, 2025 687,500.00
Dec 31, 2024 732,929.00
Dec 31, 2024 732,929.00
Sep 30, 2024 799,522.00
Sep 30, 2024 799,522.00
Jun 30, 2024 849,957.00
Jun 30, 2024 849,957.00
Mar 31, 2024 894,992.00
Mar 31, 2024 894,992.00